JP2023550998A5 - - Google Patents
Info
- Publication number
- JP2023550998A5 JP2023550998A5 JP2023532401A JP2023532401A JP2023550998A5 JP 2023550998 A5 JP2023550998 A5 JP 2023550998A5 JP 2023532401 A JP2023532401 A JP 2023532401A JP 2023532401 A JP2023532401 A JP 2023532401A JP 2023550998 A5 JP2023550998 A5 JP 2023550998A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- antigen
- binding fragment
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011364033.6 | 2020-11-27 | ||
| CN202011364033 | 2020-11-27 | ||
| PCT/CN2021/133514 WO2022111633A1 (en) | 2020-11-27 | 2021-11-26 | Cldn18.2 antibody and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550998A JP2023550998A (ja) | 2023-12-06 |
| JP2023550998A5 true JP2023550998A5 (https=) | 2024-12-04 |
Family
ID=81712708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532401A Pending JP2023550998A (ja) | 2020-11-27 | 2021-11-26 | Ｃｌｄｎ１８．２抗体及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250270313A1 (https=) |
| EP (1) | EP4251652A4 (https=) |
| JP (1) | JP2023550998A (https=) |
| KR (1) | KR20230113578A (https=) |
| CN (1) | CN114560941B (https=) |
| AU (1) | AU2021388650A1 (https=) |
| CA (1) | CA3199212A1 (https=) |
| WO (1) | WO2022111633A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4495140A4 (en) * | 2022-03-18 | 2026-03-18 | Sunshine Lake Pharma Co Ltd | Humanized Anti-Claudin 18.2 Antibody and its Use |
| CN114836388A (zh) * | 2022-06-07 | 2022-08-02 | 江苏亲科生物研究中心有限公司 | Claudin18.2单克隆抗体及其制备方法和用途 |
| CN115960229B (zh) * | 2022-09-28 | 2024-02-09 | 华润生物医药有限公司 | 一种cldn18.2抗体及其应用 |
| TW202440623A (zh) * | 2022-11-28 | 2024-10-16 | 美商艾洛基因醫療公司 | 靶向密連蛋白１８﹒２之嵌合抗原受體及結合劑以及其用途 |
| CN115873111B (zh) * | 2022-12-19 | 2024-06-07 | 华润生物医药有限公司 | 一种cldn18.2抗体及其应用 |
| CN117229415A (zh) * | 2022-12-30 | 2023-12-15 | 邦恩泰(山东)生物医药科技集团股份有限公司 | 一种靶向Claudin18.2的嵌合抗原受体、CAR-T细胞及应用 |
| CN116143924A (zh) * | 2023-02-07 | 2023-05-23 | 深圳市先康达生命科学有限公司 | 靶向人Claudin18.2蛋白的人源化单克隆抗体及其应用 |
| CN116536274B (zh) * | 2023-06-20 | 2023-09-19 | 上海精翰生物科技有限公司 | Claudin18.2表达稳转细胞株、制备方法及应用 |
| CN117777307B (zh) * | 2023-09-26 | 2024-08-20 | 深圳豪石生物科技有限公司 | 一种cldn18.2特异性嵌合t细胞受体、嵌合t细胞受体免疫细胞及其应用 |
| WO2026020019A1 (en) * | 2024-07-17 | 2026-01-22 | Mayo Foundation For Medical Education And Research | Molecules that bind to claudin polypeptides |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3266311B2 (ja) | 1991-05-02 | 2002-03-18 | 生化学工業株式会社 | 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤 |
| US8840902B2 (en) * | 2010-03-16 | 2014-09-23 | Biontech Ag | Tumor vaccination involving a humoral immune response against self-proteins |
| US9163090B2 (en) * | 2012-05-07 | 2015-10-20 | Cellerant Therapeutics, Inc. | Antibodies specific for CLL-1 |
| IL319047A (en) * | 2015-08-28 | 2025-04-01 | Amunix Operating Inc | Chimeric polypeptide composition and methods for its preparation and use |
| KR102896085B1 (ko) * | 2018-01-15 | 2025-12-08 | 스티흐팅 산퀸 불드포르지닝 | 인자 h 강화 항체 및 이의 사용 |
| EP3872093A4 (en) * | 2018-10-22 | 2022-10-19 | Shanghai Genbase Biotechnology Co., Ltd. | ANTI-CLDN18.2 ANTIBODIES AND USES THEREOF |
| KR20210110339A (ko) * | 2018-12-28 | 2021-09-07 | 난징 진스크립트 바이오테크 컴퍼니 리미티드 | 클라우딘18.2 결합 모이어티 및 그 용도 |
| CN109762067B (zh) * | 2019-01-17 | 2020-02-28 | 北京天广实生物技术股份有限公司 | 结合人Claudin 18.2的抗体及其用途 |
| KR20210148216A (ko) * | 2019-04-01 | 2021-12-07 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 항-클라우딘 18.2 항체 및 이의 응용 |
-
2021
- 2021-11-26 CN CN202111421855.8A patent/CN114560941B/zh active Active
- 2021-11-26 KR KR1020237021077A patent/KR20230113578A/ko active Pending
- 2021-11-26 CA CA3199212A patent/CA3199212A1/en active Pending
- 2021-11-26 AU AU2021388650A patent/AU2021388650A1/en active Pending
- 2021-11-26 WO PCT/CN2021/133514 patent/WO2022111633A1/en not_active Ceased
- 2021-11-26 JP JP2023532401A patent/JP2023550998A/ja active Pending
- 2021-11-26 EP EP21897133.1A patent/EP4251652A4/en active Pending
- 2021-11-26 US US18/254,689 patent/US20250270313A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023550998A5 (https=) | ||
| US12421292B2 (en) | Anti-DLL3 chimeric antigen receptors and uses thereof | |
| JP7195142B2 (ja) | 改善された血清アルブミン結合性免疫グロブリン可変ドメイン | |
| CN112154157A (zh) | 抗ror1抗体及其用途 | |
| TW201837174A (zh) | 抗ｇｐｒｃ５ｄ抗體及包含該抗體之分子 | |
| JP2020508655A5 (https=) | ||
| JP2013502913A5 (https=) | ||
| JP2019504617A5 (https=) | ||
| JP2025508118A (ja) | 新規免疫調節剤の開発および使用 | |
| WO2022068854A1 (en) | Antibodies targeting human claudin 18.2 and uses thereof | |
| JP2018522888A5 (https=) | ||
| RU2018104703A (ru) | Опухолеспецифичное антитело против egfr и его применение | |
| EP4303234A1 (en) | Antibody against nkp46 and application of antibody | |
| JP2016529213A5 (https=) | ||
| JP2023547662A (ja) | Ｃｌｄｎ６及びｃｄ３に選択的に結合するポリペプチド構築物 | |
| EP4421095A1 (en) | Anti-mesothelin nanobodies and use thereof | |
| CN114423451A (zh) | 用于多聚抗体受体靶向的材料和方法 | |
| JP2024539079A5 (https=) | ||
| CN114075288B (zh) | 抗pd-l2抗体 | |
| WO2023281120A1 (en) | Dimeric protein complexes and uses thereof | |
| WO2018179302A1 (ja) | 抗ポドプラニン抗体 | |
| CN120399073A (zh) | 一种靶向tigit的单域抗体 | |
| JP2024514101A5 (https=) | ||
| CN119798438B (zh) | 一种抗ccr8单克隆抗体及其应用 | |
| WO2025253250A1 (en) | Engineered trop2/nectin4 dual binding antibodies and uses thereof |